Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/09/057674
CTRI/2023/09/057674
Not yet recruiting
Phase 3

An observational study of the efficacy and safety comparing 10% Retinol peel and 70% Glycolic acid peel in the treatment of Acanthosis Nigricans

CHERUKUPALLI ANANTH0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: L83- Acanthosis nigricans

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: L83- Acanthosis nigricans
Sponsor
CHERUKUPALLI ANANTH
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
CHERUKUPALLI ANANTH

Eligibility Criteria

Inclusion Criteria

  • •CLINICALLY DIAGNOSED AND CONSENTING PATIENTS WITH ACANTHOSIS NIGRICANS

Exclusion Criteria

  • •1\. Patients with Post inflammatory hyperpigmentation and other facial dermatoses.
  • •2\. Pregnant and Lactating women.
  • •3\. Patients who are on topicals/systemic retinoids and other de\-pigmenting agents.
  • •4\. Non\-consenting patients.
  • •5\. Patients with unrealistic expectations.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
An observational study of the safety and efficacy of nivolumab as adjuvant treatment for esophageal cancer using the Comprehensive Registry of Esophageal Cancer in the National Clinical Database.Esophageal cancer or esophagogastric cancer
JPRN-UMIN000050925Japanese Foundation For Cancer Research1,750
Recruiting
Not Applicable
Observational study on HAL lower limb model, non medical for non-acute strokeon-acute strokeStroke, non-acute, gait disturbanceD020521
JPRN-jRCT1030220498akajima Takashi10
Recruiting
Phase 4
Efficacy, safety and tolerability assessment of Betafree eye drops in patients with Glaucoma or Ocular Hypertensio
CTRI/2018/09/015854Micro Labs Limited
Not yet recruiting
Not Applicable
Observational study to find out efficacy and safety of Bifidobacterium longum W11 plus Fructooligosaccharide combination in patients with irritable bowel syndromeHealth Condition 1: K519- Ulcerative colitis, unspecified
CTRI/2024/07/070510Abbott India Ltd
Not yet recruiting
Not Applicable
An observational study of Controlled Release Nitroglycerin in patients with angina.
CTRI/2018/10/016215Care Lifescience Private Limited